Serono Seeks Acquisitions Or Merger Instead of Take-Over
Filed in archive Corporate and Industrial News on April 11, 2006
After more than 5 months searching for a bidder, Geneva-based biotech company Serono is launching a search for acquisitions or a merger instead.
In November, when biopharmaceutical giants were considering taking over the company, its shares soared. But following this announcement, shares slipped, making it even less worth that before Serono announced it was for sale.
Analysts say the firm could seek a similar-sized partner in the consolidating European pharmaceuticals sector, possibly Germany's Schwartz or Belgium-based UCB. According to Chief Financial Officer Stuart Grant, "acquisitions were most likely in oncology and auto-immune disease, the areas where the firm is currently strongest", but that he would not rule out other areas.
Read more from Forbes, Reuters, and MarketWatch.

Tags: merger biotech serono acquisitions over merger+instead acquisitions+merger serono+seeks
Vote for Serono Seeks Acquisitions Or Merger Instead of Take-Over:
|
Rating: 7.00 out of 4 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
